Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive Panel for Immunotherapy in Low-Grade Glioma.

World neurosurgery - 1 Mar 2024

Lv Qingqing, Zhang Zhaoyu, Fu Haijuan, Li Danyang, Liu Yihao, Sun Yingnan, Wu Minghua

Abstract excerpt

BACKGROUND: The main treatment of low-grade glioma (LGG) is still surgical resection followed by radiotherapy and/or chemotherapy, which has certain limitations, including side effects and drug resistance. Immunotherapy is a promising treatment for LGG, but it is generally hindered by the tumor microenvironment with the limited expression of tumor antigens. METHODS: We integrated RNA sequencing data sets and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma
Share to Immunotherapy
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Tumor Microenvironment

Source

Identifiers

PMID: 38216032
DOI: 10.1016/j.wneu.2024.01.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive Panel for Immunotherapy in Low-Grade Glioma.PMID 38216032Read ↗

Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics.Semantic proximity Read ↗

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine developmentSemantic proximity Read ↗

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade GliomaSemantic proximity Read ↗

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomasSemantic proximity Read ↗

Identification and Validation of RNA Methylation-Related Related Alternative Splicing Gene Signature for Low Grade Glioma to Predict Survival and Immune LandscapesSemantic proximity Read ↗

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.Semantic proximity Read ↗

Association Between Tumor Mutation Burden and Prognosis in Lower-Grade Glioma: An Exploratory Study Semantic proximity Read ↗

Developing a Novel Prognostic Model for Low-grade Glioma Based on m6A-Associated Immune Genes and Identifying a New BiomarkerSemantic proximity Read ↗

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.Semantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

LGG subtypes based on the activity changes of immunologic and hallmark gene sets in cancerSemantic proximity Read ↗

Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.